IP Library Granted Patent US 10,654,902
Granted Patent B2
US 10,654,902 · App. 14/513,797 · Granted May 19, 2020

Methods and compositions for the display of polypeptides on the pili of Gram-positive bacteria

Inventors: June R. Scott (Atlanta, GA); Dorothea Zähner (Atlanta, GA); Bernard Quigley (Atlanta, GA)
Assignee: Emory University
C07K14/315A61K39/0258A61K39/07A61K39/09A61K39/092C07K14/245C12N9/52C12N15/62C12N15/746C12P21/02C12Y304/22A61K35/12A61K39/00A61K2039/523A61K2039/6068C07K2319/02C07K2319/035C07K2319/35
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,654,902
App. No.
14/513,797
Granted
May 19, 2020
Kind
B2
Abstract

Provided herein are methods and compositions for the display of polypeptides of interest on the tip of pili of Gram-positive bacteria. According to the present invention, the polypeptide of interest is amino terminal to a Gram-positive bacterial pilus tip protein or an active variant or fragment thereof, wherein the active variant or fragment comprises a cleaved cell wall sorting signal (CWSS) motif. The Gram-positive bacterium displaying a polypeptide of interest on the tip of pili that are disclosed herein are useful, for example, in methods for immunizing a subject with an antigen and methods for removing contaminants from a composition.

Claims (9)

1. A recombinant nucleic acid encoding a pilus tip fusion protein comprising an antigen fused to a carboxy-terminus of a fragment of Cpa (SEQ ID NO: 101) comprising a cell wall sorting signal (CWSS) motif, wherein the CWSS is VPPTG (SEQ ID NO: 10) and wherein the pilus tip fusion protein comprises an amino-terminal sec-dependent signal sequence.

2. The recombinant nucleic acid of claim 1 wherein the fragment of Cpa comprising the CWSS motif comprises is a polypeptide having at least 50% sequence identity to SEQ ID NO: 101.

3. The recombinant nucleic acid of claim 1 wherein the amino-terminal dec-dependent signal sequence is a polypeptide having at least 40% sequence identity to SEQ ID NO: 100.

4. The recombinant nucleic acid of claim 1 further comprising genes sipA2, tee3, and srtC2.

5. An expression cassette comprising the recombinant nucleic acid of claim 1 .

6. A vector comprising the expression cassette of claim 5 .

7. The expression cassette of claim 5 further comprising genes sipA2, tee3, and srtC2.

8. A pili expressing bacteria comprising the recombinant nucleic acid of claim 1 and a nucleic acid comprising genes sipA2, tee3, and srtC2, wherein expression of the genes and the pilus tip fusion protein localizes the pilus tip fusion protein to the tip of pili.

9. The recombinant nucleic acid of claim 1 wherein the fragment of Cpa is SEQ ID NO: 4.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 27, 2015
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034818/0409 →
CONFIRMATORY LICENSE Recorded Oct 30, 2014
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034113/0130 →
Continuity (4)
Continuation 12990264
Provisional Application 61126883 · May 8, 2008
Provisional Application 61088250 · Aug 12, 2008
Related Publication 20160304567A1 · Oct 20, 2016